Amila Orucevic

1.1k total citations
33 papers, 935 citations indexed

About

Amila Orucevic is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, Amila Orucevic has authored 33 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 10 papers in Oncology and 7 papers in Surgery. Recurrent topics in Amila Orucevic's work include Breast Cancer Treatment Studies (11 papers), Nitric Oxide and Endothelin Effects (7 papers) and HER2/EGFR in Cancer Research (4 papers). Amila Orucevic is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Nitric Oxide and Endothelin Effects (7 papers) and HER2/EGFR in Cancer Research (4 papers). Amila Orucevic collaborates with scholars based in United States, Canada and Germany. Amila Orucevic's co-authors include Peeyush K. Lala, R. Eric Heidel, John L. Bell, John F. Bechberger, Timothy R. Billiar, Richard A. Shapiro, Victor E. Gould, Ángel Alonso, Nerea Martı́nez and Timothy J. Panella and has published in prestigious journals such as Cancer Research, American Journal Of Pathology and British Journal of Cancer.

In The Last Decade

Amila Orucevic

29 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amila Orucevic United States 16 406 272 269 229 122 33 935
Qinghua Xiong United States 15 538 1.3× 637 2.3× 515 1.9× 157 0.7× 84 0.7× 20 1.3k
Keyvan Mahboubi United States 15 173 0.4× 700 2.6× 284 1.1× 166 0.7× 140 1.1× 22 1.3k
Anja J. Stauber United States 12 207 0.5× 612 2.3× 375 1.4× 97 0.4× 48 0.4× 13 1.0k
Micheline J. Moussalli United States 20 233 0.6× 646 2.4× 174 0.6× 85 0.4× 87 0.7× 23 1.4k
Gabriella Cirmena Italy 18 229 0.6× 383 1.4× 188 0.7× 133 0.6× 31 0.3× 41 813
Satoshi Iwasa Japan 16 190 0.5× 560 2.1× 289 1.1× 144 0.6× 44 0.4× 26 964
Kristin M. Daumer United States 8 618 1.5× 717 2.6× 260 1.0× 99 0.4× 46 0.4× 8 1.2k
Sandra Guaita‐Esteruelas Spain 16 345 0.8× 775 2.8× 388 1.4× 92 0.4× 36 0.3× 25 1.2k
Agnès Brouet Belgium 10 223 0.5× 428 1.6× 151 0.6× 251 1.1× 71 0.6× 11 936
Caroline Holm Sweden 14 178 0.4× 547 2.0× 319 1.2× 136 0.6× 109 0.9× 17 887

Countries citing papers authored by Amila Orucevic

Since Specialization
Citations

This map shows the geographic impact of Amila Orucevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amila Orucevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amila Orucevic more than expected).

Fields of papers citing papers by Amila Orucevic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amila Orucevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amila Orucevic. The network helps show where Amila Orucevic may publish in the future.

Co-authorship network of co-authors of Amila Orucevic

This figure shows the co-authorship network connecting the top 25 collaborators of Amila Orucevic. A scholar is included among the top collaborators of Amila Orucevic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amila Orucevic. Amila Orucevic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Orucevic, Amila, et al.. (2017). Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data. Breast Cancer Research and Treatment. 163(1). 51–61. 75 indexed citations
4.
Orucevic, Amila, R. Eric Heidel, & John L. Bell. (2016). Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis. Breast Cancer Research and Treatment. 157(3). 427–435. 55 indexed citations
5.
Orucevic, Amila, Jason Chen, James M. McLoughlin, et al.. (2015). Is the TNM Staging System for Breast Cancer Still Relevant in the Era of Biomarkers and Emerging Personalized Medicine for Breast Cancer - An Institution's 10-year Experience. The Breast Journal. 21(2). 147–154. 25 indexed citations
6.
7.
8.
9.
Orucevic, Amila, Vijaya B. Reddy, Kenneth J. Bloom, et al.. (2002). Predictors of Lymph Node Metastasis in T1 Breast Carcinoma, Stratified by Patient Age. The Breast Journal. 8(6). 349–355. 9 indexed citations
10.
Gould, Victor E., Amila Orucevic, Hanswalter Zentgraf, et al.. (2002). Nup88 (karyoporin) in human malignant neoplasms and dysplasias: Correlations of immunostaining of tissue sections, cytologic smears, and immunoblot analysis. Human Pathology. 33(5). 536–544. 46 indexed citations
11.
Gould, Victor E., Nerea Martı́nez, Amila Orucevic, J. Schneider, & Ángel Alonso. (2000). A Novel, Nuclear Pore-Associated, Widely Distributed Molecule Overexpressed in Oncogenesis and Development. American Journal Of Pathology. 157(5). 1605–1613. 41 indexed citations
12.
Orucevic, Amila, et al.. (2000). Fine-needle aspiration of extranodal and extramedullary hematopoietic malignancies. Diagnostic Cytopathology. 23(5). 318–321. 12 indexed citations
13.
Orucevic, Amila, et al.. (2000). Nitric oxide (NO), methylation and TIMP-1 expression in BL6 melanoma cells transfected with MHC class I genes. Clinical & Experimental Metastasis. 18(4). 329–335. 7 indexed citations
14.
Orucevic, Amila, et al.. (1999). Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. International Journal of Cancer. 81(6). 889–896. 114 indexed citations
15.
Lala, Peeyush K. & Amila Orucevic. (1998). Role of nitric oxide in tumor progression: Lessons from experimental tumors. Cancer and Metastasis Reviews. 17(1). 91–106. 176 indexed citations
16.
Orucevic, Amila & Peeyush K. Lala. (1998). Role of nitric oxide in IL-2 therapy-induced capillary leak syndrome. Cancer and Metastasis Reviews. 17(1). 127–142. 31 indexed citations
17.
Lala, Peeyush K., et al.. (1997). Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice. International Journal of Cancer. 73(3). 371–380. 59 indexed citations
18.
19.
20.
Orucevic, Amila & Peeyush K. Lala. (1995). NG-Nitro-L-Arginine Methyl Ester, an Inhibitor of Nitric Oxide Synthesis, Ameliorates Interleukin-2-induced Capillary Leak Syndrome in Healthy Mice. Journal of Immunotherapy. 18(4). 210–220. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qinghua Xiong Breakdown of academic impact, for papers by Keyvan Mahboubi Breakdown of academic impact, for papers by Anja J. Stauber Breakdown of academic impact, for papers by Micheline J. Moussalli Breakdown of academic impact, for papers by Gabriella Cirmena Breakdown of academic impact, for papers by Satoshi Iwasa Breakdown of academic impact, for papers by Kristin M. Daumer Breakdown of academic impact, for papers by Sandra Guaita‐Esteruelas Breakdown of academic impact, for papers by Agnès Brouet Breakdown of academic impact, for papers by Caroline Holm
Rankless by CCL
2026